Research & Publications
The Pulmonary Hypertension Center at Yale is involved in industry sponsored studies of combination therapy in pulmonary arterial hypertension treatment. This involved looking at established therapies usually used alone and seeing if further gains can be made by using them together.
The Center is participating in the RESPIRE registry, looking at factors that influence patient compliance with inhaled iloprost therapy.
We are also interested in pulmonary arterial blood and systemic serial blood sample testing for a variety of biomarkers that may prove to be useful in knowing if treatments are working or failing in this disease, and a biorepository and database currently being developed.
Specialized Terms: Pulmonary Arterial Hypertension; Combination Therapy in Pulmonary Arterial Hypertension; Biomarkers to follow treatment success in Pulmonary Arterial Hypertension
Hypertension, Pulmonary; Pulmonary Medicine; Iloprost; Biomarkers, Pharmacological
- Initial diagnostic testing in the evaluation of pulmonary hypertension.Trow TK. Initial diagnostic testing in the evaluation of pulmonary hypertension. Advances in Pulmonary Hypertension 2005 4:11-14.
- Pulmonary Hypertension. In Lang F, editor, Encyclopedia of Molecular Mechanisms of Disease.Trow TK, McLauglin VV. Pulmonary Hypertension. In Lang F, editor, Encyclopedia of Molecular Mechanisms of Disease. 1st edition, Heidelberg: Spring-Verlag; 2009. pp 1771-1773.